ASSERTIO THERAPEUTICS, INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2025-03-01: Study NCT06158620; Company role Collaborator; Phase Phase 1, Phase 2; Status Recruiting.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2025-03-01 | NCT06158620 Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease | Collaborator Lead: University of Texas Southwestern Medical Center | Phase 1, Phase 2 | Recruiting | Post Operative Pain; Urolithiasis; Ureter Calculi; Stent Complication | 80 | 2027-12-01 |